Fig. 1

a Risk of PE in sickle cell disease patients vs controls without sickle cell disease. b Risk of VTE in sickle cell disease patients vs controls without sickle cell disease
a Risk of PE in sickle cell disease patients vs controls without sickle cell disease. b Risk of VTE in sickle cell disease patients vs controls without sickle cell disease